The abstract is read at the publisher; the summary is JClub's.
Reduced LC3B and GABARAPL1 levels are linked to clear cell renal cell carcinoma, contrasting with chromophobe RCC and benign oncocytoma in matched tumor and normal tissues.
- Why it matters: Autophagy’s cancer roles vary, but its subtype-specific behavior in renal cell carcinoma is insufficiently characterized, limiting insight into development and treatment response.
- What they did: Autophagy markers were measured by immunostaining, immunoblotting, and quantitative PCR in biobanked fresh-frozen RCC tumor and matched normal tissues, and drug assays tested autophagy modulation in metastatic RCC spheroids.
- The result: Clear cell RCC shows lower autophagy marker levels than chromophobe RCC and benign oncocytoma, and metastatic RCC cell line spheroids exhibit autophagy dependencies that may inform subtype-targeted therapeutic approaches.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.